Nadler Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Nadler Financial Group's GILD Position: Q2 2026 in Review
Nadler Financial Group increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,120 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #120.
Nadler Financial Group first reported a position in GILD in Q3 2014 and has held it in 21 quarters since. The position peaked at $371K in Q4 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nadler Financial Group held 2,120 shares of Gilead Sciences worth $268K as of Q2 2026.
- Nadler Financial Group bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
- Gilead Sciences made up 0.02% of Nadler Financial Group's portfolio in Q2 2026, its #120 holding.
- Nadler Financial Group first reported a position in Gilead Sciences in Q3 2014 and has held it in 21 quarters since.
- Nadler Financial Group's Gilead Sciences position peaked at $371K in Q4 2015.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.